XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Operating activities:      
Net income $ 24,653 $ 50,537 $ 25,245
(Income) loss from discontinued operations (527) (865) 4,394
Income from continuing operations 24,126 49,672 29,639
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation expense   13,505 8,113
Amortization and impairments to operating lease assets   17,340 28,612
Depreciation 10,656 20,714 21,461
Amortization of intangible assets 16,176 20,010 34,704
Amortization and write-off of debt discount and issuance costs   2,310 6,819
Provision for bad debts 8,284 23,024 14,275
Deferred income taxes   (343) (245)
Loss on disposals, accelerated depreciation, and impairments to property and equipment   38 3,483
Gain on extinguishment of debt 0 0 (71)
(Gain) loss on investments 4,049 (575) 4,950
Unrealized loss on assets held for sale 0 647 0
Changes in assets and liabilities:      
Accounts receivable   (42,429) (25,045)
Prepaid expenses and other current assets   (2,143) 494
Accounts payable   7,824 13,233
Accrued payroll and benefits   (6,073) (25,295)
Accrued liabilities   25,130 (4,849)
Deferred revenue   (13,540) (28,424)
Operating lease liabilities   (20,441) (25,923)
Other assets and liabilities   (11,601) (13,654)
Net cash provided by operating activities-continuing operations   83,069 42,277
Net cash provided by (used in) operating activities-discontinued operations   9,515 (862)
Net cash provided by operating activities   92,584 41,415
Investing activities:      
Capital expenditures   (30,328) (9,747)
Proceeds from sale of marketable securities   626 1,256
Purchases of marketable securities   (498) (1,257)
Net cash used in investing activities-continuing operations   (30,200) (9,748)
Payment for working capital adjustment for sale of business     (3,174)
Net cash used in investing activities   (30,200) (12,922)
Financing activities:      
Proceeds from exercise of stock options   15,313 1,422
Employee taxes paid on withholding shares   (6,505) (4,108)
Proceeds from stock issued under Colleague Stock Purchase Plan   359 289
Repurchases of common stock for treasury   (160,549)  
Payment on equity forward contract     (13,162)
Repayments of long-term debt     (150,861)
Net cash used in financing activities   (151,382) (166,420)
Net decrease in cash, cash equivalents and restricted cash   (88,998) (137,927)
Cash, cash equivalents and restricted cash at beginning of period   275,075 347,937
Cash, cash equivalents and restricted cash at end of period $ 210,010 186,077 210,010
Non-cash investing and financing activities:      
Accrued capital expenditures   9,062 $ 5,209
Accrued liability for repurchases of common stock   2,400  
Accrued excise tax on share repurchases   $ 2,358